Bill & Melinda Gates Medical Research Institute
- Country
- πΊπΈUnited States
- Ownership
- Private
- Established
- 2017-01-01
- Employees
- 101
- Market Cap
- -
- Website
- https://www.gatesmri.org
A Trial in Healthy Adult Participants to Evaluate the Safety, Tolerability, and Behavior in the Body of TBD11
- First Posted Date
- 2024-11-27
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- Bill & Melinda Gates Medical Research Institute
- Target Recruit Count
- 108
- Registration Number
- NCT06707142
- Locations
- πΊπΈ
Celerion, Lincoln, Nebraska, United States
Study To Evaluate Safety, Tolerability, and Pharmacokinetics of MAM01 in African Population
- Conditions
- Interventions
- First Posted Date
- 2024-05-10
- Last Posted Date
- 2024-10-30
- Lead Sponsor
- Bill & Melinda Gates Medical Research Institute
- Target Recruit Count
- 139
- Registration Number
- NCT06408857
- Locations
- πΊπ¬
JCRC-Joint Clinical Research Centre, Kampala, Uganda
πΊπ¬IDRC-Infectious Disease Research Collaboration, IDRC Tororo Hospital Station Road, Tororo, Uganda
Study to Assess Efficacy and Safety of M72/AS01E-4 Mycobacterium Tuberculosis (Mtb) Vaccine in Adolescents and Adults
- Conditions
- Interventions
- First Posted Date
- 2023-10-02
- Last Posted Date
- 2024-11-08
- Lead Sponsor
- Bill & Melinda Gates Medical Research Institute
- Target Recruit Count
- 20000
- Registration Number
- NCT06062238
- Locations
- πΏπ²
Gates MRI Investigational Site, Ndola, Zambia
πΏπ¦Gates MRI Investigational Site #1, Tembisa, South Africa
Efficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PBOS in Adults With Pulmonary Tuberculosis
- Conditions
- Interventions
- First Posted Date
- 2023-08-02
- Last Posted Date
- 2024-10-01
- Lead Sponsor
- Bill & Melinda Gates Medical Research Institute
- Target Recruit Count
- 514
- Registration Number
- NCT05971602
- Locations
- π΅π
Lung Center of the Philippines, Quezon City, Philippines
πΏπ¦The Aurum Institute (Tembisa CRS), Johannesburg, South Africa
πΏπ¦Perinatal HIV Research Unit (PHRU), Klerksdorp, South Africa
Impact of Bi-26 Supplementation on Weight Gain in Underweight Infants
- Conditions
- Interventions
- First Posted Date
- 2023-07-19
- Last Posted Date
- 2024-12-11
- Lead Sponsor
- Bill & Melinda Gates Medical Research Institute
- Target Recruit Count
- 40
- Registration Number
- NCT05952076
- Locations
- π΅π°
Medical Facility A, Islamabad, Islamabad Capital Territory, Pakistan
π΅π°Medical Facility B, Islamabad, Islamabad Capital Territory, Pakistan
π΅π°Medical Facility C, Islamabad, Islamabad Capital Territory, Pakistan
Safety, Tolerability, Pharmacokinetics and Protective Efficacy of MAM01 in Healthy Adults
- First Posted Date
- 2023-06-06
- Last Posted Date
- 2024-10-29
- Lead Sponsor
- Bill & Melinda Gates Medical Research Institute
- Target Recruit Count
- 61
- Registration Number
- NCT05891236
- Locations
- πΊπΈ
Center for Vaccine Development and Global Health, 685 W. Baltimore Street, Baltimore, Maryland, United States
Safety, Tolerability, Pharmacokinetics (PK), and Food Effect of MK-7762 in Healthy Adults
- First Posted Date
- 2023-04-21
- Last Posted Date
- 2024-07-26
- Lead Sponsor
- Bill & Melinda Gates Medical Research Institute
- Target Recruit Count
- 119
- Registration Number
- NCT05824091
- Locations
- πΊπΈ
Investigational Site, Lincoln, Nebraska, United States
Epidemiologic Study to Assess the IGRA Positivity in Populations With a High TB Burden
- Conditions
- First Posted Date
- 2022-01-13
- Last Posted Date
- 2024-12-13
- Lead Sponsor
- Bill & Melinda Gates Medical Research Institute
- Target Recruit Count
- 7203
- Registration Number
- NCT05190146
- Locations
- πΏπ²
Investigational Site, Ndola, Zambia
Safety, Tolerability, and Pharmacokinetics of RSV Monoclonal Antibody RSM01 in Healthy Adults
- First Posted Date
- 2021-11-12
- Last Posted Date
- 2024-05-20
- Lead Sponsor
- Bill & Melinda Gates Medical Research Institute
- Target Recruit Count
- 56
- Registration Number
- NCT05118386
- Locations
- πΊπΈ
PPD Phase I Clinic - Orlando, Orlando, Florida, United States
Proof of Concept Trial of Adjuvant Activity of SWE, a Squalene-based -Oil-in-water Emulsion
- First Posted Date
- 2021-09-05
- Last Posted Date
- 2022-11-17
- Lead Sponsor
- Bill & Melinda Gates Medical Research Institute
- Registration Number
- NCT05035680